Literature DB >> 10975567

Five recombinant fragments of human serum albumin-tools for the characterization of the warfarin binding site.

M Dockal1, M Chang, D C Carter, F Rüker.   

Abstract

Human serum albumin (HSA) interacts with a vast array of chemically diverse ligands at specific binding sites. To pinpoint the essential structural elements for the formation of the warfarin binding site on human serum albumin, a defined set of five recombinant proteins comprising combinations of domains and/or subdomains of the N-terminal part were prepared and characterized by biochemical standard procedures, tryptophanyl fluorescence, and circular dichroic measurements, indicating well-preserved secondary and tertiary structures. Affinity constants for binding to warfarin were estimated by fluorescence titration experiments and found to be highest for HSA-DOM I-II and HSA, followed by HSA-DOM IB-II, HSA-DOM II, and HSA-DOM I-IIA. In addition, ultraviolet difference spectroscopy and induced circular dichroism experiments were carried out to get an in depth understanding of the binding mechanism of warfarin to the fragments as stand-alone proteins. This systematic study indicates that the primary warfarin binding site is centered in subdomain IIA with indispensable structural contributions of subdomain IIB and domain I, while domain III is not involved in this binding site, underlining the great potential that lies in the use of combinations of recombinant fragments for the study and accurate localization of ligand binding sites on HSA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975567      PMCID: PMC2144726          DOI: 10.1110/ps.9.8.1455

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  49 in total

1.  Partially folded state of the disulfide-reduced form of human serum albumin as an intermediate for reversible denaturation.

Authors:  J Y Lee; M Hirose
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

2.  Atomic structure and chemistry of human serum albumin.

Authors:  X M He; D C Carter
Journal:  Nature       Date:  1992-07-16       Impact factor: 49.962

3.  Calculation of protein extinction coefficients from amino acid sequence data.

Authors:  S C Gill; P H von Hippel
Journal:  Anal Biochem       Date:  1989-11-01       Impact factor: 3.365

4.  Comparison of graphical procedures for estimating the intrinsic molar fluorescence of protein-bound drugs for drug-binding studies. A reevaluation of existing plots and introduction of two inverse hyperbolic plots.

Authors:  K M Rajkowski
Journal:  Biochem Pharmacol       Date:  1990-03-01       Impact factor: 5.858

5.  Mechanism by which warfarin binds to human serum albumin. Stopped-flow kinetic experiments with two large fragments of albumin.

Authors:  O J Bos; M J Fischer; J Wilting; L H Janssen
Journal:  Biochem Pharmacol       Date:  1989-06-15       Impact factor: 5.858

6.  Location and characterization of the warfarin binding site of human serum albumin. A comparative study of two large fragments.

Authors:  O J Bos; J P Remijn; M J Fischer; J Wilting; L H Janssen
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

Review 7.  Structure of serum albumin.

Authors:  D C Carter; J X Ho
Journal:  Adv Protein Chem       Date:  1994

8.  Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.

Authors:  V Maes; Y Engelborghs; J Hoebeke; Y Maras; A Vercruysse
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

9.  A comparison of drug binding sites on mammalian albumins.

Authors:  M R Panjehshahin; M S Yates; C J Bowmer
Journal:  Biochem Pharmacol       Date:  1992-09-01       Impact factor: 5.858

Review 10.  Structure and ligand binding properties of human serum albumin.

Authors:  U Kragh-Hansen
Journal:  Dan Med Bull       Date:  1990-02
View more
  17 in total

1.  Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment.

Authors:  Steve Seung-Young Lee; Junjie Li; Jien Nee Tai; Timothy L Ratliff; Kinam Park; Ji-Xin Cheng
Journal:  ACS Nano       Date:  2015-02-16       Impact factor: 15.881

2.  Structural insights into human serum albumin-mediated prostaglandin catalysis.

Authors:  Jinsheng Yang; Charles E Petersen; Chung-Eun Ha; Nadhipuram V Bhagavan
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

3.  Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains.

Authors:  Da Shi; Yin-xiu Jin; Yi-hong Tang; Hai-hong Hu; Si-yun Xu; Lu-shan Yu; Hui-di Jiang; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2012-05       Impact factor: 6.150

4.  Binding of tolbutamide to glycated human serum albumin.

Authors:  K S Joseph; Jeanethe Anguizola; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2010-09-15       Impact factor: 3.935

5.  Chromatographic analysis of acetohexamide binding to glycated human serum albumin.

Authors:  K S Joseph; Jeanethe Anguizola; Abby J Jackson; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-08-21       Impact factor: 3.205

6.  Functional analysis of recombinant human serum albumin domains for pharmaceutical applications.

Authors:  Sadaharu Matsushita; Yu Isima; Victor Tuan Giam Chuang; Hiroshi Watanabe; Sumio Tanase; Tomu Maruyama; Masaki Otagiri
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

7.  Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding.

Authors:  Yu Cao; Francesco P Nicoletti; Giampiero De Sanctis; Alessio Bocedi; Chiara Ciaccio; Francesca Gullotta; Gabriella Fanali; Grazia R Tundo; Alessandra di Masi; Mauro Fasano; Giulietta Smulevich; Paolo Ascenzi; Massimo Coletta
Journal:  J Biol Inorg Chem       Date:  2011-09-06       Impact factor: 3.358

8.  Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.

Authors:  K S Joseph; Annette C Moser; Sara B G Basiaga; John E Schiel; David S Hage
Journal:  J Chromatogr A       Date:  2008-10-01       Impact factor: 4.759

9.  Binding and relaxometric properties of heme complexes with cyanogen bromide fragments of human serum albumin.

Authors:  Enrico Monzani; Maria Curto; Monica Galliano; Lorenzo Minchiotti; Silvio Aime; Simona Baroni; Mauro Fasano; Angela Amoresano; Anna Maria Salzano; Piero Pucci; Luigi Casella
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

10.  Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin.

Authors:  Paolo Ascenzi; Alessandra di Masi; Massimo Coletta; Chiara Ciaccio; Gabriella Fanali; Francesco P Nicoletti; Giulietta Smulevich; Mauro Fasano
Journal:  J Biol Chem       Date:  2009-09-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.